Induction of cytosolic clofibroyl-CoA hydrolase activity in liver of rats treated with clofibrate. 1987

R K Berge, and E Stensland, and A Aarsland, and G Tsegai, and H Osmundsen, and N Aarsaether, and D R Gjellesvik

Among subcellular fractions of liver homogenates of rats, the clofibroyl-CoA hydrolase activity is found mainly in the cytosolic fraction. It is here shown that the subcellular distribution of clofibroyl-CoA hydrolase appears to be different from the distribution of palmitoyl-CoA hydrolase activity. Thus, in contrast to the case with palmitoyl-CoA, no hydrolysis of clofibroyl-CoA was catalysed by the microsomal fraction. Furthermore, the hydrolysis of palmitoyl-CoA and clofibroyl-CoA in the cytosolic fraction seemed to be catalyzed by two different enzymes. Rats treated with clofibrate (0.3%, w/w) showed a significant increased clofibroyl-CoA hydrolase activity where the cytosolic hydrolase was increased 3.5-fold. Clofibrate administration also elevated the specific clofibroyl-CoA hydrolase activity by factors of 1.7 and 1.5 in the mitochondrial and the light-mitochondrial fractions, respectively. Thus, it is possible that clofibroyl-CoA hydrolase has also a multiorganelle localization.

UI MeSH Term Description Entries
D007770 L-Lactate Dehydrogenase A tetrameric enzyme that, along with the coenzyme NAD+, catalyzes the interconversion of LACTATE and PYRUVATE. In vertebrates, genes for three different subunits (LDH-A, LDH-B and LDH-C) exist. Lactate Dehydrogenase,Dehydrogenase, L-Lactate,Dehydrogenase, Lactate,L Lactate Dehydrogenase
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D010171 Palmitoyl Coenzyme A A fatty acid coenzyme derivative which plays a key role in fatty acid oxidation and biosynthesis. Palmitoyl CoA,Hexadecanoyl CoA,Palmityl CoA,CoA, Hexadecanoyl,CoA, Palmitoyl,CoA, Palmityl,Coenzyme A, Palmitoyl
D002994 Clofibrate A fibric acid derivative used in the treatment of HYPERLIPOPROTEINEMIA TYPE III and severe HYPERTRIGLYCERIDEMIA. (From Martindale, The Extra Pharmacopoeia, 30th ed, p986) Athromidin,Atromid,Atromid S,Clofibric Acid, Ethyl Ester,Ethyl Chlorophenoxyisobutyrate,Miscleron,Miskleron,Chlorophenoxyisobutyrate, Ethyl
D003600 Cytosol Intracellular fluid from the cytoplasm after removal of ORGANELLES and other insoluble cytoplasmic components. Cytosols
D004790 Enzyme Induction An increase in the rate of synthesis of an enzyme due to the presence of an inducer which acts to derepress the gene responsible for enzyme synthesis. Induction, Enzyme
D006868 Hydrolysis The process of cleaving a chemical compound by the addition of a molecule of water.
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013869 Thiolester Hydrolases Hydrolases, Thiolester

Related Publications

R K Berge, and E Stensland, and A Aarsland, and G Tsegai, and H Osmundsen, and N Aarsaether, and D R Gjellesvik
July 1979, European journal of biochemistry,
R K Berge, and E Stensland, and A Aarsland, and G Tsegai, and H Osmundsen, and N Aarsaether, and D R Gjellesvik
April 1993, Biochemical pharmacology,
R K Berge, and E Stensland, and A Aarsland, and G Tsegai, and H Osmundsen, and N Aarsaether, and D R Gjellesvik
August 1986, Biochemical pharmacology,
R K Berge, and E Stensland, and A Aarsland, and G Tsegai, and H Osmundsen, and N Aarsaether, and D R Gjellesvik
November 1987, Bioscience reports,
R K Berge, and E Stensland, and A Aarsland, and G Tsegai, and H Osmundsen, and N Aarsaether, and D R Gjellesvik
February 1994, Journal of biochemistry,
R K Berge, and E Stensland, and A Aarsland, and G Tsegai, and H Osmundsen, and N Aarsaether, and D R Gjellesvik
October 1984, Biochemical pharmacology,
R K Berge, and E Stensland, and A Aarsland, and G Tsegai, and H Osmundsen, and N Aarsaether, and D R Gjellesvik
February 1981, FEBS letters,
R K Berge, and E Stensland, and A Aarsland, and G Tsegai, and H Osmundsen, and N Aarsaether, and D R Gjellesvik
May 2001, European journal of biochemistry,
R K Berge, and E Stensland, and A Aarsland, and G Tsegai, and H Osmundsen, and N Aarsaether, and D R Gjellesvik
March 1985, Proceedings of the National Academy of Sciences of the United States of America,
R K Berge, and E Stensland, and A Aarsland, and G Tsegai, and H Osmundsen, and N Aarsaether, and D R Gjellesvik
March 2007, Xenobiotica; the fate of foreign compounds in biological systems,
Copied contents to your clipboard!